Close Menu
PNN DigitalPNN Digital
    Facebook X (Twitter) Instagram
    PNN DigitalPNN Digital
    • Business
    • National
    • Entertainment
    • Lifestyle
    • Education
    • Press Release
    • Submit Your PR
    PNN DigitalPNN Digital
    Home - Business - Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr
    Business

    Thyrocare Q4FY25 Revenue Up 21 Percent YoY to Rs 187.2 Cr; PAT Rises 24 Percent to Rs 21.3 Cr

    SunilBy SunilApril 25, 2025Updated:April 26, 2025No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Navi Mumbai (Maharashtra) [India], April 24: Thyrocare Technologies Limited (hereinafter referred to as “Thyrocare” NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, announces their results for the quarter ended March 31, 2025. For Q4FY25, the company reported revenue from operations of INR 187.2 crore, reflecting a 21% year-over-year (YoY) growth. Normalized EBITDA for the quarter stood at INR 65.3 crore, marking a robust 78% YoY increase. Profit after tax (PAT), excluding exceptional items, reached INR 32.5 crore, which represents an impressive 88% YoY growth.

    Key highlights for Q4FY25:

    • Consolidated revenue increased by 21% year-over-year (YoY) with Pathology and Radiology segments growing by 23% YoY and 7% YoY respectively
    • Total volume in FY25 grew to 167.9 million, largest by far on volume
    • Revenue from franchise surged by 22% YoY, and partnership revenue saw 24% YoY growth
    • Consolidated gross margin stood at 74%, and normalized EBITDA margin was 35%
    • Standalone normalized EBITDA grew by 72% YoY, while PAT* increased by 72% YoY
    • Consolidated normalized EBITDA grew by 78% YoY, while PAT* increased by 88% YoY
    • Recommended a final dividend of INR 21 per equity share subject to the approval of shareholders at the ensuing shareholders meeting
    • Consolidated cash reserves as of March 2025 is INR 191.8 Cr
    • Opened new labs in Bhagalpur and Kashmir

    Consolidated income statement for Q4FY25 and FY25:

    QuarterAnnual
    INR CroreQ4FY25Q4FY24YoYFY25FY24YoY
    Revenue from operations187.2154.221%687.3571.920%
    Gross margin137.7107.628%496.2405.222%
    Normalized EBITDA (before ESOP)65.336.778%209.9153.137%
    Reported EBITDA57.433.870%189.2137.837%
    Profit after tax incl. exceptional item21.317.224%90.069.829%
    Profit after tax excl. exceptional item32.517.288%101.269.845%
    Key metrics
    Gross margin%74%70%72%71%
    Normalized EBITDA%35%24%31%27%
    Reported EBITDA%31%22%28%24%
    PAT incl. exceptional item%11%11%13%12%
    PAT excl. exceptional item%17%11%14%12%


    * PAT excluding exceptional item of INR 11.2 Cr pertaining to reversal of deferred tax asset created in previous years against the impairment of investment in NHL.

    If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

    Thyrocare Technologies Limited
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Sunil

      Related Posts

      Astro Parduman’s Revolutionary Seminar Blending Astro, Numero & Vastu in Hisar

      June 2, 2025

      Anusaya Fresh Brings Raj Kapoor USA Blueberries to Indian Homes

      June 2, 2025

      IFFCO’s Historic Performance: Record Profit in 2024-25, 47% Surge in Nano Fertilizer Sales

      May 31, 2025
      Add A Comment

      Comments are closed.

      Recent Posts
      • ITCONS E-Solutions Reports 100 Percent Revenue Growth in FY 2024-25 Over Previous Fiscal
      • Astro Parduman’s Revolutionary Seminar Blending Astro, Numero & Vastu in Hisar
      • Anusaya Fresh Brings Raj Kapoor USA Blueberries to Indian Homes
      • IFFCO’s Historic Performance: Record Profit in 2024-25, 47% Surge in Nano Fertilizer Sales
      • Digant Sharma Joins Global Leaders at Europe-Asia Economic Economic in Davos

      ITCONS E-Solutions Reports 100 Percent Revenue Growth in FY 2024-25 Over Previous Fiscal

      June 2, 2025

      Astro Parduman’s Revolutionary Seminar Blending Astro, Numero & Vastu in Hisar

      June 2, 2025

      Anusaya Fresh Brings Raj Kapoor USA Blueberries to Indian Homes

      June 2, 2025

      IFFCO’s Historic Performance: Record Profit in 2024-25, 47% Surge in Nano Fertilizer Sales

      May 31, 2025

      Digant Sharma Joins Global Leaders at Europe-Asia Economic Economic in Davos

      May 31, 2025

      Er. Sudhir Kumar Sahu: The Visionary Engineer Redefining Literature Through Myth and Markets

      May 31, 2025
      PNN Digital
      2025 © pnn.digital

      Type above and press Enter to search. Press Esc to cancel.